Literature DB >> 24831659

Total number of lymph node metastases is a more significant risk factor for poor prognosis than positive lateral lymph node metastasis.

Yoichiro Homma1, Takashi Hamano, Yoshiro Otsuki, Shinichi Shimizu, Yasuyuki Kobayashi.   

Abstract

PURPOSE: Lateral lymph nodes (LLNs) along the iliac vessels are an important indicator of local recurrence; however, we are unaware of any study that investigates whether the number of LLN metastases influences the prognosis of patients with lower rectal cancer.
METHOD: We analyzed retrospectively the records of 154 patients who underwent radical resection of T1-4 lower rectal adenocarcinoma at a single institution.
RESULTS: Among the 88.3 % of patients who underwent LLN dissection, 13 (8.4 %) had LLN metastasis. The Cox proportional hazard model indicated that sex, histological grade, lymphatic or venous invasion, and LLN metastasis were not significantly associated with tumor recurrence, whereas tumor depth and more than three lymph node metastases were risk factors for recurrence (p = 0.002 and p = 0.02, respectively). Of the 13 patients with LLN metastasis, 6 whose mesenteric lymph nodes (MLNs) had been well dissected and examined did not have MLN metastasis.
CONCLUSIONS: The presence of one or two LLN metastases in patients who have undergone LLN dissection with surgery for lower rectal cancer is not associated with poor prognosis. The number of LLN metastases is a more significant risk factor for poor prognosis.

Entities:  

Mesh:

Year:  2014        PMID: 24831659     DOI: 10.1007/s00595-014-0913-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

Review 1.  [General rules for management of cancer of the colon and the rectum].

Authors:  Takeo Mori; Keiichi Takahashi; Tatsuro Yamaguchi; Hiroshi Matsumoto
Journal:  Nihon Rinsho       Date:  2003-09

2.  Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Authors:  Tae Hyun Kim; Seung-Yong Jeong; Dong Hyun Choi; Dae Yong Kim; Kyung Hae Jung; Sung Ho Moon; Hee Jin Chang; Seok-Byung Lim; Hyo Seong Choi; Jae-Gahb Park
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

Review 3.  Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.

Authors:  Panagiotis Georgiou; Emile Tan; Nikolaos Gouvas; Anthony Antoniou; Gina Brown; R John Nicholls; Paris Tekkis
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

4.  Indication and benefit of pelvic sidewall dissection for rectal cancer.

Authors:  Kenichi Sugihara; Hirotoshi Kobayashi; Tomoyuki Kato; Takeo Mori; Hidetaka Mochizuki; Shingo Kameoka; Kazuo Shirouzu; Tetsuichiro Muto
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

5.  Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.

Authors:  M Ueno; M Oya; K Azekura; T Yamaguchi; T Muto
Journal:  Br J Surg       Date:  2005-06       Impact factor: 6.939

6.  Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus.

Authors:  R J Heald
Journal:  Br J Surg       Date:  1995-10       Impact factor: 6.939

7.  Lymphoscintigraphy in patients with primary rectal cancer: the role of total mesorectal excision for primary rectal cancer--a lymphoscintigraphic study.

Authors:  Peter Sterk; Lothar Keller; Hans Jochims; Peter Klein; Friedrich Stelzner; Hans Peter Bruch; Uwe Markert
Journal:  Int J Colorectal Dis       Date:  2002-05       Impact factor: 2.571

8.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

9.  Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.

Authors:  Hirotoshi Kobayashi; Hidetaka Mochizuki; Tomoyuki Kato; Takeo Mori; Shingo Kameoka; Kazuo Shirouzu; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

10.  Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers.

Authors:  Yoichiro Homma; Takashi Hamano; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Yasuyuki Kobayashi
Journal:  J Surg Oncol       Date:  2010-09-01       Impact factor: 3.454

View more
  3 in total

1.  Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.

Authors:  Michelle Kang Kim; Richard R P Warner; Stephen C Ward; Noam Harpaz; Sasan Roayaie; Myron E Schwartz; Steven Itzkowitz; Juan Wisnivesky
Journal:  Neuroendocrinology       Date:  2015-01-05       Impact factor: 4.914

2.  Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.

Authors:  Bin Zeng; Yu Min; Yang Feng; Ke Xiang; Hang Chen; Zijing Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-20       Impact factor: 6.055

3.  Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.

Authors:  Sicheng Zhou; Yujuan Jiang; Wei Pei; Jianwei Liang; Zhixiang Zhou
Journal:  BMC Cancer       Date:  2022-02-03       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.